Journal
BLOOD
Volume 113, Issue 3, Pages 723-725Publisher
AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2008-09-179333
Keywords
-
Categories
Funding
- Hungarian National Research Fund, Budapest, Hungary [OTKA K62087, OTKA-NKTH NI69238]
- Hungarian Academy of Sciences, Budapest, Hungary [2006TKI227]
- Hungarian Ministry of Health, Budapest, Hungary [ETT406/2006]
Ask authors/readers for more resources
Acquired factor XIII (FXIII) deficiency due to autoantibody against FXIII is a very rare severe hemorrhagic diathesis. Antibodies directed against the A subunit of FXIII, which interfere with different functions of FXIII, have been described. Here, for the first time, we report an autoantibody against the B subunit of FXIII (FXIII-B) that caused life-threatening bleeding in a patient with systemic lupus erythematosus. FXIIIactivity, FXIII-A(2)B(2) complex, and individual FXIII sub-units were undetectable in the plasma, whereas platelet FXIII activity and antigen were normal. Neither FXIII activation nor its activity was inhibited by the antibody, which bound to structural epitope(s) on both free and complexed FXIII-B. The autoantibody highly accelerated the elimination of FXIII from the circulation. FXIII supplementation combined with immunosuppressive therapy, plasmapheresis, immunoglobulin, and antiCD20 treatment resulted in the patient's recovery. FXIII levels returned to around 20% at discharge and after gradual increase the levels stabilized above 50%. (Blood. 2009; 113: 723-725)
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available